On Wednesday, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)’s shares inclined 0.78% to $69.57.
Teva Pharmaceutical Industries Ltd. (TEVA) declared that the New Drug Application (NDA) for SD-809 (deutetrabenazine) has been accepted by the U.S. Food and Drug Administration (FDA) for the treatment of chorea associated with Huntington disease (HD), a rare and fatal neurodegenerative disorder caused by the progressive breakdown of nerve cells in the brain that affects about five to seven people per 100,000 in western countries, according to the World Health Organization.
The NDA filing is based on positive results from two Phase-III studies, FIRST-HD and ARC-HD. In the placebo-controlled, randomized FIRST-HD study, SD-809 reduced chorea in patients with HD. Positive top-line data from the Phase-III, open-label ARC-HD study demonstrated that patients were able to safely convert from tetrabenazine, presently the only approved HD treatment, to SD-809 overnight with continued control of chorea.
SD-809 was granted Orphan Drug Designation for the treatment of HD by the FDA in November 2014 and became part of Teva’s CNS portfolio with the acquisition of Auspex Pharmaceuticals in May 2015.
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic, specialty, and other pharmaceutical products worldwide. The company operates in two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers generic or branded generic medicines; specialized products, such as sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances; and active pharmaceutical ingredients.
Michael Kors Holdings Ltd (NYSE:KORS)’s shares gained 0.70% to $43.18.
Michael Kors (KORS), a global luxury lifestyle brand, is happy to declare that Daisuke Yamazaki has been named President of Japan, following the retirement of Toshi Tashiro. Mr. Yamazaki will report to Stephane Lafay, the Company’s President of Asia. Mr. Yamazaki’s appointment is effective August 10, 2015, and Mr. Tashiro will stay on through the end of 2015 in order to ensure a smooth transition of responsibilities.
Mr. Yamazaki most recently served as CEO of Roberto Cavalli Japan. Formerly, he was the CEO of the Alexander McQueen Division, at Gucci Japan Limited. Preceding to that he spent 15 years at Giorgio Armani Japan, where he held a variety of positions, counting heading sales and merchandising for both the women’s and men’s lines.
Michael Kors Holdings Limited engages in the design, marketing, distribution, and retailing of branded woman’s apparel and accessories, and men’s apparel. The company operates in three segments: Retail, Wholesale, and Licensing. The Retail segment is involved in the sale of women’s apparel; accessories, which comprise handbags and small leather goods, such as wallets; footwear; and licensed products comprising watches, jewelry, fragrances and beauty, and eyewear. As of March 28, 2015, this segment operated 343 North American retail stores, counting concessions and its U.S. e-commerce site; and 183 international retail stores, counting concessions in Europe and Japan.
At the end of Wednesday’s trade, Mastercard Inc (NYSE:MA)‘s shares dipped -1.01% to $96.61.
First Tech Federal Credit Union declared a pilot program with MasterCard that will enable First Tech employees to authenticate and verify transactions using facial recognition and fingerprint biometrics.
The pilot program will run in September and October and comprise over 200 credit union employees. Pilot participants will use smartphone apps to make virtual donations to the Children’s Miracle Network (CMN) Hospitals, all authenticated by facial recognition or fingerprint biometrics. MasterCard and First Tech are proud to support CMN Hospitals, a nonprofit organization raising funds and awareness for 170 children’s hospitals across North America.
First Tech and MasterCard introduced the concept for this biometrics pilot program at the White House Cyber Security Summit held at Stanford University in California on February 9.
The pilot program builds on existing activities by MasterCard and CardinalCommerce to power First Tech Federal Credit Union’s cardholder verification processes.
MasterCard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally. The company facilitates the processing of payment transactions, counting authorization, clearing, and settlement, in addition to delivers related products and services. It also offers value-added services, such as loyalty and reward programs, and information and consulting services.
Stericycle Inc (NASDAQ:SRCL), ended its Wednesday’s trading session with 0.01% gain, and closed at $148.26.
Stericycle, Inc. (SRCL) will host investor meetings on Tuesday, September 1st by Dan Ginnetti, CFO, at the Barrington Research Fall Investment Conference in Chicago.
On Wednesday, September 16th Stericycle will give a presentation by Mr. Ginnetti, at 9:55 AM Eastern time at the Morgan Stanley Global Healthcare Conference in New York.
On Thursday, September 17th Stericycle will give a presentation by Mr. Ginnetti, at Imperial Capital’s 9th Annual Global Opportunities Conference in New York.
Stericycle, Inc., together with its auxiliaries, provides regulated and compliance solutions to the healthcare and commercial businesses. The company collects and processes specialized waste for disposal services. Its regulated solutions comprise hazardous waste administration, Steri-Safe medical waste and compliance programs, clinical services programs, Bio Systems reusable sharps containers, pharmaceutical waste disposal, medical safety products, and integrated waste stream solutions program. The company’s compliance solutions comprise training, consulting, inbound/outbound communications, data reporting, and other regulatory compliance services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
